In the chronic asthma protocol, rhBMP-7 was administered during the fibrogenic phase of asthma by intranasal instillation of 300 μg/kg in a total volume of 30 μl of BMP-7 every other day between days 17 and 30. This evidence concerns the gene BMP7 and chronic asthma.